NewslettersHepatic Cell NewsHuman Immunology News Sitravatinib Targets TYRO3 to Augment the Anti-Tumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma By Jamie Kang - May 13, 2025 0 468 Scientists investigated the anti-tumor efficacy and immunomodulatory activity of sitravatinib in hepatocellular carcinoma. [Clinical Cancer Research] Abstract